ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 65 filers reported holding ENZO BIOCHEM INC in Q3 2021. The put-call ratio across all filers is 3.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $138,000 | +15.0% | 39,041 | +3.1% | 0.01% | +33.3% |
Q2 2021 | $120,000 | -9.1% | 37,878 | -1.1% | 0.01% | -25.0% |
Q1 2021 | $132,000 | +34.7% | 38,306 | -2.0% | 0.01% | +14.3% |
Q4 2020 | $98,000 | -22.8% | 39,086 | -34.9% | 0.01% | +75.0% |
Q3 2020 | $127,000 | -42.0% | 60,047 | -38.6% | 0.00% | -33.3% |
Q2 2020 | $219,000 | +73.8% | 97,742 | +95.7% | 0.01% | +100.0% |
Q1 2020 | $126,000 | +5.9% | 49,952 | +9.9% | 0.00% | +50.0% |
Q4 2019 | $119,000 | -33.5% | 45,432 | -8.4% | 0.00% | 0.0% |
Q3 2019 | $179,000 | – | 49,605 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roumell Asset Management, LLC | 2,392,642 | $6,939,000 | 11.21% |
VIEX Capital Advisors, LLC | 1,435,130 | $4,162,000 | 7.44% |
HARBERT FUND ADVISORS, INC. | 5,175,913 | $15,010,000 | 6.29% |
Potomac Capital Management, Inc. | 496,805 | $1,441,000 | 1.24% |
AMH Equity Ltd | 30,000 | $87,000 | 0.09% |
Corsair Capital Management | 75,026 | $218,000 | 0.05% |
RBF Capital, LLC | 250,359 | $730,000 | 0.05% |
KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $74,000 | 0.04% |
BOOTHBAY FUND MANAGEMENT, LLC | 539,954 | $1,566,000 | 0.04% |
Cutter & CO Brokerage, Inc. | 25,777 | $75,000 | 0.02% |